Hello, everyone, and how are you today? We hope the weekend was relaxing and invigorating, because now, of course, that routine of meetings, deadlines and what-not has resumed. We are no different, though, and so to cope, yes, we are once again brewing a cup of stimulation - Pumpkin Spice, in keeping with the season. Meanwhile, here are some tidbits that we hope will get you started on your day. Have a good one and keep in touch if you hear anything interesting...
Masschusetts Compounder Has Background In Recycling (Associated Press)
Abbott Hep C Drug Combo Clears Virus In Most Patients (Bloomberg News)
New Psychiatric Drugs Are A Low Priority For Pharma (CBC)
Glaxo Reverses Plant Closure In Ireland (The Independent)
AstraZeneca Expands R&D In China To Boost Discovery (Bloomberg News)
Indian Pharma Regs Should Not Change To Suit Others (InPharma Technologist)
Merck Osteoporosis Drug Builds Bone Density In Mid-Stage Trial (Reuters)
Analysts Sour On Bristol-Myers Stock (Bloomberg News)
Biogen Says New Look At Data Bolsters Oral MS Drug (Reuters)
Drug Price Drops Expected In Ireland Next Month (Irish Times)
CVS Is Unaware Of Any Probe Into Prescription Refills (Reuters)
Merck Gets Rights To HCMV Drug From Bayer Spin Off (Pharma Times)
Teva Opens New Plant In Hungary (Globes)
EDITOR’S NOTE: Please check this post for updates
sunshine pic thx to benimoto on flickr
1 Comment
Read Robert Whitaker's excellent book "Anatomy of An Epidemic", the chapter Blueprint for Reform, to read about effective and humane mental health treatment.